Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ―― Live and ...
Weekly Trust on MSN
Sickle Cell: I Still Have Crisis - Adekunle Gold
Nigerian singer, Adekunle Gold, has disclosed that he continues to experience sickle cell crisis, despite managing the condition since childhood.In a recent interview with Nandoleaks, the ...
Sickle cell disease, a genetic blood disorder, disproportionately affects Black individuals, with one in 365 Black babies born with it in the U.S. New, high-cost gene therapies offer potential cures ...
Despite years of chronic pain and health issues from sickle cell disease, Candis King always loved looking out for others. At Colgan High School, she was known as someone who brought extra clothes for ...
RICHMOND, Va. — They say twins share everything, a birthday, a bond, a heartbeat. But for one Richmond family, those shared moments include a pain that only strengthened their determination and drive.
A newly unveiled street sign honoring sickle cell warrior Gerbuns Augustin marked a major milestone for Miami-Dade’s sickle cell community, but it’s also a reminder that the fight against the disease ...
When Shekea Lindsay of Tonawanda found out that her newborn daughter, MaKenzie, was born with sickle cell anemia, she was shocked. She knew she carried the trait for the inherited blood disorder, but ...
BROWARD COUNTY, Fla. — A South Florida family is happy their son no longer lives with chronic pain. Plus, he’s the first in the area to go through FDA-approved gene therapy. Caden Major had been ...
Prairie View is launching its Student Sickle Cell Warrior Project, a first-of-its-kind program designed to support college students living with SCD. According to the Red Cross, sickle cell disease ...
ORCHARD PARK, N.Y. — Bills quarterback Josh Allen will showcase a special piece of fan-designed gear at Thursday night's home game against the Miami Dolphins. As part of his ongoing partnership with ...
Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of participants with severe sickle cell disease. The therapy led to substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results